Results 131 to 140 of about 14,442 (179)

Allergic Reactions to Measles-Mumps-Rubella Vaccination

Pediatrics, 2001
Objective.Immunization of egg-allergic children against measles, mumps, and rubella (MMR) is often deferred or even denied, although the safety of this vaccination has been clearly shown. Moreover, the majority of severe allergic reactions have occurred in egg-tolerant vaccinees.
A, Patja, S, Mäkinen-Kiljunen, I, Davidkin, M, Paunio, H, Peltola   +4 more
openaire   +2 more sources

Combination Measles, Mumps, Rubella, and Varicella Vaccine

Pediatrics, 1986
A comparative clinical trial was conducted in 15- to 17-month-old healthy children to compare an investigational combination measles, mumps, rubella, varicella (MMRV) vaccine v standard measles, mumps, rubella vaccine followed 6 weeks later with the varicella (MMR+V) vaccine.
A M, Arbeter, L, Baker, S E, Starr, B L, Levine, E, Books, S A, Plotkin   +5 more
openaire   +2 more sources

Autism and Measles-Mumps-Rubella Vaccination

CNS Drugs, 2001
It has been suggested that vaccination, particularly with measles-mumps-rubella (MMR) vaccine, may be related to the development of autism. The main evidence for a possible association is that the prevalence of autism has been increasing at the same time that infant vaccination coverage has increased, and that in some cases there is an apparent ...
F, DeStefano, R T, Chen
openaire   +2 more sources

Measles-Mumps-Rubella Vaccine and Autism

Pediatrics, 2003
To the Editor .— The recent article by Makela et al1 provides no meaningful data on any possible association between the measles-mumps-rubella (MMR) vaccine and autism. This manufacturer-supported study is biased toward a negative result. Using hospital admissions is designed to underestimate the …
openaire   +2 more sources

Measles–Mumps–Rubella Vaccine

2017
The measles–mumps–rubella (MMR) vaccine is currently the exclusive tool for the prevention of measles, mumps, and rubella in Europe. The description below of single measles, mumps, and rubella vaccines is given for historical reasons and for the characterization of their properties as components of the MMR vaccine.
Timo Vesikari, Vytautas Usonis
openaire   +1 more source

Measles-mumps-rubella vaccine and the development of autism

Seminars in Pediatric Infectious Diseases, 2003
The measles-mumps-rubella (MMR) vaccine has been postulated to cause a form of autism characterized by regression and bowel symptoms, and onset occurring shortly after vaccination. It is also claimed that, as a result, there has been a dramatic increase in autism prevalence.
openaire   +2 more sources

Closer look at autism and the measles-mumps-rubella vaccine

Journal of the American Pharmacists Association, 2010
To educate pharmacists regarding the hypothesis that the measles-mumps-rubella (MMR) vaccine is linked to the development of autism.Articles published from 1998 to 2009 were identified through electronic searches of Medline.Articles were included if they evaluated or reviewed a possible link between the MMR vaccine and autism or discussed MMR ...
Emily, Hensley, Leslie, Briars
openaire   +2 more sources

Response to measles-mumps-rubella vaccine in children on dialysis

Pediatric Nephrology, 1992
Ten children receiving maintenance dialysis were immunized with the standard dose of measles-mumps-rubella vaccine between 15 and 33 months of age. Immune responses to vaccination were determined using commercially available enzyme-linked immunosorbent assays for measles, mumps, and rubella viruses.
S L, Schulman, A, Deforest, B A, Kaiser, M S, Polinsky, H J, Baluarte   +4 more
openaire   +2 more sources

Is an Improved Measles-Mumps-Rubella Vaccine Necessary or Feasible?

Critical Reviews in Immunology, 2003
The measles-mumps-rubella (MMR) vaccine has been very effective in the elimination of disease and has high biosafety. However, it has been associated with several adverse effects and has recently caused controversy with regard to its possible association with inflammatory bowel disease and autism.
Gregory J, Atkins, S Louise, Cosby
openaire   +2 more sources

Two Doses of Measles Mumps Rubella (MMR) Vaccine

Pediatrics International, 1989
A schedule of two doses of measles mumps rubella vaccine (MMR) at an interval of six weeks was tried in children aged between 12 and 48 months. One hundred percent seroconversion was attained in the measles HI (hemagglutinin inhibition) test, rubella HI test, and mumps ELISA test in both groups of children who received NIH (National Institute of Health,
H, Kuno-Sakai, K, Ozaki, M, Kimura
openaire   +2 more sources